First-Line Treatment for Whooping Cough (Pertussis)
Azithromycin is the first-line treatment for pertussis (whooping cough) due to its effectiveness, better tolerability, and convenient dosing schedule compared to other macrolides. 1
Treatment Recommendations by Age Group
Infants < 1 month
- Azithromycin is the preferred macrolide for treatment and postexposure prophylaxis 1
- Erythromycin is not recommended due to risk of infantile hypertrophic pyloric stenosis (IHPS) 2, 3
- Infants receiving macrolides should be monitored for IHPS and other serious adverse events 2
Infants 1-5 months
- Azithromycin: 10 mg/kg per day for 5 days 2
- Clarithromycin is also considered a first-line agent based on in vitro effectiveness, safety, and convenient dosing 2
Infants ≥ 6 months and children
- Azithromycin: 10 mg/kg (maximum: 500 mg) on day 1, followed by 5 mg/kg per day (maximum: 250 mg) on days 2-5 2, 1
- Clarithromycin is an acceptable alternative 1
Adults
Alternative Treatment Options
- For patients aged >2 months with macrolide contraindications, trimethoprim-sulfamethoxazole (TMP-SMZ) is recommended 2
- Erythromycin (40-50 mg/kg/day in 4 divided doses for 14 days in children; 2 g per day in 4 divided doses for 14 days in adults) is effective but has more side effects and requires longer treatment duration 2, 4
Efficacy and Clinical Considerations
- Early antibiotic treatment (during the catarrhal phase, first 2 weeks) is most effective in:
- Short-term antibiotics (azithromycin for 3-5 days) are as effective as long-term (erythromycin for 10-14 days) in eradicating B. pertussis from the nasopharynx 5
- Patients should be isolated at home and away from work or school for 5 days after starting antibiotic therapy 2
Side Effects and Precautions
- Azithromycin and clarithromycin are better tolerated and associated with fewer and milder side effects than erythromycin 2
- Common side effects of macrolides include:
- Azithromycin should not be taken with aluminum- or magnesium-containing antacids as they reduce absorption 2, 1
- Macrolides are contraindicated in patients with history of hypersensitivity to any macrolide agent 2
Postexposure Prophylaxis
- The same antimicrobial agents and dosing regimens used for treatment are recommended for postexposure prophylaxis 2, 1
- Prophylaxis should be administered to close contacts, especially in exposure settings that include:
Clinical Course and Prognosis
- Approximately 80-90% of patients with untreated pertussis will spontaneously clear B. pertussis from the nasopharynx within 3-4 weeks from onset of cough 2
- Untreated and unvaccinated infants can remain culture-positive for >6 weeks 2
- While antibiotics effectively eliminate B. pertussis from the nasopharynx, they may not significantly alter the subsequent clinical course if started late in the disease 5